$3.56 0.14 (+4.09%)
2/9/2010 4:00 PM

Orthovita, Inc. (VITA)

CAPS Rating: 5 out of 5

A spine and orthopedic biosurgery company which develops and markets synthetic-based biomaterial products for use in spine surgery, the repair of fractures and a range of clinical needs in the trauma, joint reconstruction, revision and extremities markets

Current Price $3.56 Mkt Cap $272.33M
Open $0.00 P/E Ratio 0.00
Prev. Close $3.56 Div. (Yield) N/A (N/A)
Daily Range $3.42 - $3.57 Volume 240,206
52-Wk Range $2.56 - $6.91 Avg. Daily Vol. 0

VITA News and Commentary

Caps

How do you think VITA will perform vs the S&P 500?

Add Stock to Watchlist

All Members

261 Outperform
13 Underperform
 

All-Star Members

96 Outperform
4 Underperform
 

Wall Street

7 Outperform
0 Underperform
 

Top VITA Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TSIF (98.89)
Submitted June 11, 2009

I entered a low buy order on VITA yesterday, but I doubt it will come back down to me. Orthovita has been in the "bone surgery" business for several years and it's stock had just drifted around since 2001 and is hitting an 8 year high.… More

3 Comments | Reply | Report this Post

NetscribeHealthC (28.90)
Submitted February 09, 2007

Orthovita is a biomaterials company involves in the development and commercialization of synthetic, biologically active, tissue engineering products for orthopedic and neurosurgical applications. Its products, used in the regeneration of bone,… More

0 Comments | Reply | Report this Post
VITA VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about VITA.

Recs

0
Member Avatar destroyevidence (25.58) Submitted: 2/2/2010 11:47:15 AM : Outperform Start Price: $3.73 VITA Score: -2.13

VITA @ 3.80. A small cap 285 million health care play with a great product, Cortoss (aka bone spackle), that just received FDA approval. VITA should turn profitable for the first time in a decade. Trades for about 1 times sales. Under wall street’s Radar with only 6 analysts covering. A David Gardner Rule Breaker pick with a 5 star CAPS rating. Also out of my circle of competence but I’m building a health care basket to compensate.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar realmotley (< 20) Submitted: 12/6/2009 1:22:18 PM : Outperform Start Price: $3.52 VITA Score: +4.38

Demographic Trends

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar dgu004 (48.34) Submitted: 11/17/2009 3:03:19 PM : Outperform Start Price: $3.80 VITA Score: -2.79

Looking forward to the new revenue generated by the new product line in the coming 2-3 years.

Report this Post 0 Comments | Reply | Permalink
View All 39 Pitches »

Leaderboard

Find the members with the highest scoring picks in VITA.

Score Leader

alcear

alcear (80.44) Score: +144.13

even a blind squirrel gathers a nut every once in awhile

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
jwinston05 92.39 5/9/2008 Outperform 3Y $1.90 +87.37% -20.10% +107.47
StockMutiny 32.98 5/5/2008 Outperform 3W $2.24 +58.93% -21.17% +80.10
panthermp 85.46 5/7/2008 Outperform NS $2.25 +58.22% -21.68% +79.90
TMFBreakerKevin 81.59 5/7/2008 Outperform 5Y $2.25 +58.22% -21.68% +79.90
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. drmny51 < 20 5/21/2008 Outperform 3Y $2.30 +54.78% -21.59% +76.38
natedizzle27 < 20 4/21/2008 Outperform NS $2.35 +51.49% -19.68% +71.17
hav417 85.86 6/11/2008 Outperform NS $2.34 +52.14% -18.51% +70.65
dgrotefa 49.91 3/25/2008 Outperform 1Y $2.33 +52.79% -17.55% +70.34 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. TMFBreakerJava 98.41 5/29/2008 Outperform 5Y $2.39 +48.95% -20.02% +68.98 1 Comment
rogbob1 87.63 4/24/2008 Outperform 5Y $2.40 +48.33% -19.36% +67.69
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackRodmanRen < 20 9/18/2008 Outperform NS $2.73 +30.40% -6.54% +36.94
TrackCanaccord 86.15 6/1/2007 Outperform NS $2.88 +23.61% -26.27% +49.88
TrackBreanMurray 86.47 3/28/2007 Outperform NS $2.93 +21.50% -20.25% +41.76
TrackWRHambrecht 64.18 9/25/2006 Outperform NS $3.40 +4.71% -13.61% +18.32
TrackSusquehanna 74.67 9/15/2006 Outperform NS $3.70 -3.78% -14.07% +10.28
TrackRothCapital 80.39 8/7/2006 Outperform NS $3.74 -4.81% -10.63% +5.81

Featured Broker Partners